Search results for: 'platform deal'
- Did you mean
- platform deaf
- Related search terms
- deal docs
- Deals
- deals captured since 2020
- deal
- deal captura scienc 221b
-
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00In Vitro Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Licensing Deals in Biotechnology 2019-2024September 2024$3,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Joint Venture Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.
Learn More -
Genomic Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Co-development Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More
